Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study

ConclusionsLong-term linagliptin use showed sustained improvements in glycemic control with no new safety concerns regardless of renal function.Trial RegistrationClinicalTrials.gov (NCT01650259).FundingThis study was funded by Nippon Boehringer Ingelheim Co., Ltd. and Eli Lilly Japan K.K.

Source: Diabetes Therapy - January 12, 2020 Category: Endocrinology Source Type: research